Vivimed Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE526G01021
  • NSEID: VIVIMEDLAB
  • BSEID: 532660
INR
22.75
-1.19 (-4.97%)
BSENSE

Dec 23

BSE+NSE Vol: 9.34 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 612893,
    "name": "Vivimed Labs.",
    "stock_name": "Vivimed Labs.",
    "full_name": "Vivimed Labs Ltd",
    "name_url": "stocks-analysis/vivimed-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "22.75",
    "chg": -1.19,
    "chgp": "-4.97%",
    "dir": -1,
    "prev_price": "23.94",
    "mcapval": "189.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532660,
    "symbol": "VIVIMEDLAB",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE526G01021",
    "curr_date": "Dec 23",
    "curr_time": "",
    "bse_nse_vol": "9.34 k",
    "exc_status": "Active",
    "traded_date": "Dec 23, 2025",
    "traded_date_str": "2025 12 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vivimed-labs-612893-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Vivimed Labs Hits Lower Circuit Amid Heavy Selling Pressure and Panic Selling",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivimed-labs-hits-lower-circuit-amid-heavy-selling-pressure-and-panic-selling-3766845",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VivimedLabs_stocks_hitting_lower_circuit_3766845.png",
        "date": "2025-12-23 10:00:12",
        "description": "Vivimed Labs Ltd witnessed a sharp decline on 23 Dec 2025, hitting its lower circuit limit at ₹22.81, marking a maximum daily loss of 5.0%. The stock faced intense selling pressure, with panic selling dominating trade and leaving a significant portion of supply unfilled, reflecting a challenging trading session for this micro-cap pharmaceutical company."
      }
    ],
    "total": 1,
    "sid": "612893",
    "stock_news_url": "https://www.marketsmojo.com/news/vivimed-labs-612893"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Notice Of Board Meeting / Closure Of Trading Window",
      "datetime": "28-Oct-2023",
      "details": "VIVIMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements) 2015 further to our letter dated 30.09.2023 we hereby bring to your notice that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday 14th Day of November 2023 at Hyderabad inter alia to consider and approve un-audited Financial Results (Standalone & Consolidated) of the company for the quarter and half year ended 30th September 2023. Further we would like to inform that pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 the company has intimated its Designated Persons including Directors regarding the closure of trading window from 01.10.2023 to till 48 hours after the declaration of un-audited Financial Results (Standalone & Consolidated) of the company for the quarter and half year ended 30th September 2023.",
      "source": "BSE"
    },
    {
      "caption": "Notice Of 35Th Annual General Meeting (AGM) And Book Closure For AGM.",
      "datetime": "20-Oct-2023",
      "details": "AGM on November 132023 Book Closure: November 8 2023 to November 13 2023",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "20-Oct-2023",
      "details": "Certificate under Regulation 74(5)",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Vivimed Labs Ltd has declared <strong>20%</strong> dividend, ex-date: 19 Sep 18",
          "dt": "2018-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Vivimed Labs Ltd has announced <strong>2:10</strong> stock split, ex-date: 06 Apr 16",
          "dt": "2016-04-06",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Board Meeting Intimation for Notice Of Board Meeting / Closure Of Trading Window

28-Oct-2023 | Source : BSE

VIVIMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements) 2015 further to our letter dated 30.09.2023 we hereby bring to your notice that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday 14th Day of November 2023 at Hyderabad inter alia to consider and approve un-audited Financial Results (Standalone & Consolidated) of the company for the quarter and half year ended 30th September 2023. Further we would like to inform that pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 the company has intimated its Designated Persons including Directors regarding the closure of trading window from 01.10.2023 to till 48 hours after the declaration of un-audited Financial Results (Standalone & Consolidated) of the company for the quarter and half year ended 30th September 2023.

Notice Of 35Th Annual General Meeting (AGM) And Book Closure For AGM.

20-Oct-2023 | Source : BSE

AGM on November 132023 Book Closure: November 8 2023 to November 13 2023

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

20-Oct-2023 | Source : BSE

Certificate under Regulation 74(5)

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Vivimed Labs Ltd has declared 20% dividend, ex-date: 19 Sep 18

stock-summary
SPLITS

Vivimed Labs Ltd has announced 2:10 stock split, ex-date: 06 Apr 16

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available